380 related articles for article (PubMed ID: 11494125)
41. Role of tyrosine phosphorylation in radiation-induced cell cycle-arrest of leukemic B-cell precursors at the G2-M transition checkpoint.
Tuel-Ahlgren L; Jun X; Waddick KG; Jin J; Bolen J; Uckun FM
Leuk Lymphoma; 1996 Feb; 20(5-6):417-26. PubMed ID: 8833397
[TBL] [Abstract][Full Text] [Related]
42. Genomic studies of the spleen protein tyrosine kinase locus reveal a complex promoter structure and several genetic variants.
Goodman PA; Jurana B; Wood CM; Uckun F
Leuk Lymphoma; 2002 Aug; 43(8):1627-35. PubMed ID: 12400606
[TBL] [Abstract][Full Text] [Related]
43. Differential requirements for ZAP-70 in TCR signaling and T cell development.
Kadlecek TA; van Oers NS; Lefrancois L; Olson S; Finlay D; Chu DH; Connolly K; Killeen N; Weiss A
J Immunol; 1998 Nov; 161(9):4688-94. PubMed ID: 9794398
[TBL] [Abstract][Full Text] [Related]
44. Specific immunoglobulin E responses in ZAP-70-deficient patients are mediated by Syk-dependent T-cell receptor signalling.
Toyabe S; Watanabe A; Harada W; Karasawa T; Uchiyama M
Immunology; 2001 Jun; 103(2):164-71. PubMed ID: 11412303
[TBL] [Abstract][Full Text] [Related]
45. Distinct roles for Syk and ZAP-70 during early thymocyte development.
Palacios EH; Weiss A
J Exp Med; 2007 Jul; 204(7):1703-15. PubMed ID: 17606633
[TBL] [Abstract][Full Text] [Related]
46. The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells.
Klein F; Feldhahn N; Harder L; Wang H; Wartenberg M; Hofmann WK; Wernet P; Siebert R; Müschen M
J Exp Med; 2004 Mar; 199(5):673-85. PubMed ID: 14993251
[TBL] [Abstract][Full Text] [Related]
47. A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase.
Atwell S; Adams JM; Badger J; Buchanan MD; Feil IK; Froning KJ; Gao X; Hendle J; Keegan K; Leon BC; Müller-Dieckmann HJ; Nienaber VL; Noland BW; Post K; Rajashankar KR; Ramos A; Russell M; Burley SK; Buchanan SG
J Biol Chem; 2004 Dec; 279(53):55827-32. PubMed ID: 15507431
[TBL] [Abstract][Full Text] [Related]
48. Pre-T cell receptor signals are responsible for the down-regulation of Syk protein tyrosine kinase expression.
Chu DH; van Oers NS; Malissen M; Harris J; Elder M; Weiss A
J Immunol; 1999 Sep; 163(5):2610-20. PubMed ID: 10453000
[TBL] [Abstract][Full Text] [Related]
49. Targeting SYK kinase-dependent anti-apoptotic resistance pathway in B-lineage acute lymphoblastic leukaemia (ALL) cells with a potent SYK inhibitory pentapeptide mimic.
Uckun FM; Ek RO; Jan ST; Chen CL; Qazi S
Br J Haematol; 2010 May; 149(4):508-17. PubMed ID: 20151979
[TBL] [Abstract][Full Text] [Related]
50. Distinct tyrosine phosphorylation sites in ZAP-70 mediate activation and negative regulation of antigen receptor function.
Kong G; Dalton M; Bubeck Wardenburg J; Straus D; Kurosaki T; Chan AC
Mol Cell Biol; 1996 Sep; 16(9):5026-35. PubMed ID: 8756661
[TBL] [Abstract][Full Text] [Related]
51. Differential expression levels of the heat shock protein 27 isoforms in pediatric normal, nonleukemic and common acute lymphoblastic leukemia B-cell precursors.
Madsen PS; Hokland P; Clausen N; Ellegaard J; Hokland M
Blood; 1995 Jan; 85(2):510-21. PubMed ID: 7812006
[TBL] [Abstract][Full Text] [Related]
52. Unexpected requirement for ZAP-70 in pre-B cell development and allelic exclusion.
Schweighoffer E; Vanes L; Mathiot A; Nakamura T; Tybulewicz VL
Immunity; 2003 Apr; 18(4):523-33. PubMed ID: 12705855
[TBL] [Abstract][Full Text] [Related]
53. CD19-antigen specific nanoscale liposomal formulation of a SYK P-site inhibitor causes apoptotic destruction of human B-precursor leukemia cells.
Myers DE; Yiv S; Qazi S; Ma H; Cely I; Shahidzadeh A; Arellano M; Finestone E; Gaynon PS; Termuhlen A; Cheng J; Uckun FM
Integr Biol (Camb); 2014 Aug; 6(8):766-80. PubMed ID: 24910947
[TBL] [Abstract][Full Text] [Related]
54. A single base mutation in the 5' splice site of intron 7 of the lck gene is responsible for the deletion of exon 7 in lck mRNA of the JCaM1 cell line.
Rouer E; Brule F; Benarous R
Oncogene; 1999 Jul; 18(29):4262-8. PubMed ID: 10435639
[TBL] [Abstract][Full Text] [Related]
55. Progressive loss of Syk and abnormal proliferation in breast cancer cells.
Moroni M; Soldatenkov V; Zhang L; Zhang Y; Stoica G; Gehan E; Rashidi B; Singh B; Ozdemirli M; Mueller SC
Cancer Res; 2004 Oct; 64(20):7346-54. PubMed ID: 15492255
[TBL] [Abstract][Full Text] [Related]
56. Molecular cloning of rodent p72Syk. Evidence of alternative mRNA splicing.
Rowley RB; Bolen JB; Fargnoli J
J Biol Chem; 1995 May; 270(21):12659-64. PubMed ID: 7759516
[TBL] [Abstract][Full Text] [Related]
57. Molecular characterization of the murine syk protein tyrosine kinase cDNA, transcripts and protein.
Flück M; Zürcher G; Andres AC; Ziemiecki A
Biochem Biophys Res Commun; 1995 Aug; 213(1):273-81. PubMed ID: 7639745
[TBL] [Abstract][Full Text] [Related]
58. Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.
Hotfilder M; Röttgers S; Rosemann A; Schrauder A; Schrappe M; Pieters R; Jürgens H; Harbott J; Vormoor J
Cancer Res; 2005 Feb; 65(4):1442-9. PubMed ID: 15735032
[TBL] [Abstract][Full Text] [Related]
59. Intramolecular regulatory switch in ZAP-70: analogy with receptor tyrosine kinases.
Brdicka T; Kadlecek TA; Roose JP; Pastuszak AW; Weiss A
Mol Cell Biol; 2005 Jun; 25(12):4924-33. PubMed ID: 15923611
[TBL] [Abstract][Full Text] [Related]
60. Precursor B-ALL Cell Lines Differentially Respond to SYK Inhibition by Entospletinib.
Sender S; Sekora A; Villa Perez S; Chabanovska O; Becker A; Ngezahayo A; Junghanss C; Murua Escobar H
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
